Skystar Bio-Pharmaceutical CO (SKBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,530 | 6,212 | 13,658 | 14,091 | 8,852 |
| Depreciation Amortization | 1,714 | 1,437 | 1,872 | 1,271 | 779 |
| Income taxes - deferred | -360 | N/A | N/A | N/A | N/A |
| Accounts receivable | -1,017 | -6,394 | 1,660 | -434 | -1,958 |
| Accounts payable and accrued liabilities | -985 | 2,307 | 725 | -103 | -250 |
| Other Working Capital | -17,853 | -1,994 | -16,051 | -8,728 | -9,529 |
| Other Operating Activity | 2,546 | 4,979 | -3,522 | 1,623 | 3,371 |
| Operating Cash Flow | $-5,423 | $6,546 | $-1,659 | $7,720 | $1,266 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 352 |
| PPE Investments | -169 | -556 | -7,553 | -4,127 | -3,239 |
| Purchase Of Investment | N/A | -2,023 | -3,850 | -7,841 | 295 |
| Sale Of Investment | 1,098 | 2,393 | 11,114 | N/A | 2,714 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -1,173 |
| Other Investing Activity | -3,515 | -358 | -1,366 | -4,452 | -7,976 |
| Investing Cash Flow | $-2,586 | $-545 | $-1,655 | $-16,419 | $-7,853 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,501 | 5,775 | N/A | 2,729 | 220 |
| Debt Issued | N/A | N/A | 10,857 | N/A | N/A |
| Other Financing Activity | -5,816 | -7,488 | -6,771 | -80 | 17,489 |
| Financing Cash Flow | $4,685 | $-1,713 | $4,086 | $2,650 | $17,709 |
| Exchange Rate Effect | 144 | -15 | 389 | 239 | 2 |
| Beginning Cash Position | 11,322 | 7,049 | 5,888 | 11,699 | 576 |
| End Cash Position | 8,142 | 11,322 | 7,049 | 5,888 | 11,699 |
| Net Cash Flow | $-3,180 | $4,273 | $1,161 | $-5,812 | $11,123 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,423 | 6,546 | -1,659 | 7,720 | 1,266 |
| Capital Expenditure | -169 | -556 | -7,553 | -4,127 | -3,239 |
| Free Cash Flow | -5,592 | 5,990 | -9,212 | 3,593 | -1,973 |